Invesco Pharmaceuticals ETF
PJP
96 hedge funds and large institutions have $152M invested in Invesco Pharmaceuticals ETF in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 37 reducing their positions, and 9 closing their positions.
156% more call options, than puts
Call options by funds: $782K | Put options by funds: $306K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
1% less funds holding
Funds holding: 97 → 96 (-1)
1.87% less ownership
Funds ownership: 16.85% → 14.98% (-1.9%)
21% less capital invested
Capital invested by funds: $194M → $152M (-$41.4M)
27% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$3.51M |
| 2 |
VF
Virtu Financial
New York
|
+$2.25M |
| 3 |
TSS
Two Sigma Securities
New York
|
+$787K |
| 4 |
AI
Atria Investments
Charlotte,
North Carolina
|
+$786K |
| 5 |
SG Americas Securities
New York
|
+$781K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$12.8M |
| 2 |
MWM
Merriman Wealth Management
Seattle,
Washington
|
-$5.41M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$4.66M |
| 4 |
Goldman Sachs
New York
|
-$3.78M |
| 5 |
NFC
Northeast Financial Consultants
Westport,
Connecticut
|
-$3.28M |
PJP Hedge Fund Activity: Q3 2016 in Review
96 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2016, worth a combined $152M — down 21% from $194M a quarter earlier.
Fund positioning in PJP was balanced in Q3 2016: 9 funds opened new positions, 9 closed out, 27 added to existing stakes and 37 trimmed.
The largest buyer was Jane Street, adding an estimated $3.51M. The largest seller was UBS Group, cutting an estimated $12.8M.
- 96 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2016, down from 97 in Q2 2016.
- Funds reported $152M of Invesco Pharmaceuticals ETF stock for Q3 2016, down 21% quarter-over-quarter.
- 9 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2016 and 9 closed out, a net change of 0 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2016 was Jane Street, an estimated $3.51M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2016 was UBS Group, an estimated $12.8M sold.
Based on aggregated 13F filings for Q3 2016.